Skip to main content

DCVC — Portfolio, Page 10

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

285
Companies
$5.9B
Total invested
$32.0M
Avg. check
56
Industries
Software 8Artificial Intelligence (AI) 8Machine Learning 7Health Care 6Biotechnology 4Information Technology 4+50 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 217240 of 285
Lucira Health
February 2022

Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.

Biotechnology · Emeryville$80.0M Post Ipo Debt
nTopology
November 2021

nTopology is a company that develops software used in the design and manufacturing of 3D-printed parts and products.

3D Printing · New York$65.0M Series D
Kettle
November 2021

Kettle is an insurtech company that develops a machine-learning powered reinsurer balancing risk.

Financial Services · Hamilton$25.0M Series A
Nyriad
November 2021

Nyriad is developing the industry's first storage solutions based on a new architecture that redefines how data is stored.

Computer · Austin$28.0M Series C
Zoom
November 2021

Zoom is a software company that offers a communications platform that connects people through video, voice, chat, and content sharing.

Collaboration · San Jose$130.0M Post Ipo Equity
Kentik
October 2021

Kentik is the network intelligence platform for modern infrastructure teams

Cloud Data Services · San Francisco$40.0M Series C
Pluribus Networks
October 2021

Pluribus Networks is a leader in open networking and next generation software defined networking (SDN)

Big Data · Santa Clara$20.0M Series Unknown
MindRhythm
August 2021

MindRhythm is an evolved neurodiagnostics company discovering and developing unique biometrics to solve unmet needs in medicine.

Manufacturing · Cupertino$5.0M Seed
Stemson Therapeutics
July 2021

Stemson Therapeutics is a pre-clinical stage cell therapy company.

Biotechnology · San Diego$15.0M Series A
Cape Analytics
July 2021

Cape Analytics provides AI and analytics services for properties.

Analytics · Palo Alto$44.0M Series C
Nylas
June 2021

Nylas is the cpaas company that empowers businesses worldwide to unlock the power of their communications data.

Developer APIs · San Francisco$120.0M Series C
Paperspace
May 2021

Paperspace powers next-generation applications built on GPUs.

AI Infrastructure · New York$12.0M Series Unknown
InnaMed
May 2021

InnaMed is a developer of a diagnostic device intended to provide early detection of illness.

Health Care · PhiladelphiaSeries Unknown
BioPhero
March 2021

BioPhero is a pioneer in providing low-cost bio-based pheromones for pest management.

Chemical · Lyngby$16.8M Series A
Auransa
August 2020

A clinical stage drug development company who aims to invent novel drugs for hard-to-treat diseases using its proprietary AI platform

Artificial Intelligence (AI) · Palo Alto$15.7M Series A
Pachyderm
August 2020

Pachyderm is an enterprise-grade data science platform that makes explainable, repeatable, and scalable AI/ML a reality.

Analytics · San Francisco$16.0M Series B
Virtual Power Systems
August 2020

Virtual Power Systems provides an Intelligent Control of Energy (ICE) platform that unlocks stranded power capacity in data centers.

Data Center Automation · Milpitas$12.0M Series Unknown
Qumulo
July 2020

Qumulo provides a file data platform for multi-cloud environments with large scale file data.

Big Data · Seattle$125.0M Series E
Caption Health
July 2020

Caption Health is a medical company that uses artificial intelligence (AI) to interpret ultrasound exams.

Artificial Intelligence (AI) · Brisbane$53.0M Series B
Area 1 Security
June 2020

Area 1 Security is a performance-based cybersecurity company, changing how businesses protect against phishing attacks.

Cyber Security · Redwood City$25.0M Series B
BrainSpec
April 2020

BrainSpec is a health-tech company that enables accurate, efficient, and non-invasive diagnosis of brain disorders.

Biotechnology · Boston$31K Debt Financing
X-37
November 2019

X-37 is a pharmaceutical discovery and development company

Artificial Intelligence (AI) · San Francisco$14.5M Series A
Descartes Labs
October 2019

Descartes Labs is a technology company that automates the analysis of geospatial data to help organizations answer key questions.

Agriculture · New York$20.0M Series B
Vicarious
August 2019

Vicarious is an artificial intelligence firm that uses the computational principles of the brain to develop general intelligence.

Artificial Intelligence (AI) · Union CitySeries Unknown

Where DCVC invests

Software8
Artificial Intelligence (AI)8
Machine Learning7
Health Care6
Biotechnology4
Information Technology4

About DCVC's portfolio

How many companies has DCVC invested in?

DCVC has invested in 285 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does DCVC invest in?

DCVC's top investment sectors include Software, Artificial Intelligence (AI), Machine Learning, Health Care, Biotechnology. The firm invests across 56 different industry categories.

What is DCVC's largest investment?

Among tracked funding rounds, Zoom received $130.0M in a Post Ipo Equity round. DCVC's total known invested capital is $5.9B.

What is the average investment size for DCVC?

DCVC's average investment size is $32.0M across its portfolio of 285 companies.

What are DCVC's most recent investments?

Recent DCVC portfolio additions include Lucira Health, nTopology, Kettle, Nyriad, Zoom. These companies were founded in 2020 or later.

Reach the founders behind these 285 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →